R. Barski, A. Cuddapah, S. Cui, K. Roh, T. Schones et al., High-Resolution Profiling of Histone Methylations in the Human Genome, Cell, vol.129, issue.4, pp.823-837, 2007.
DOI : 10.1016/j.cell.2007.05.009

M. Brady, D. Ozanne, L. Gaughan, I. Waite, S. Cook et al., Tip60 Is a Nuclear Hormone Receptor Coactivator, Journal of Biological Chemistry, vol.52, issue.25, pp.17599-17604, 1999.
DOI : 10.1210/me.6.5.753

URL : http://www.jbc.org/content/274/25/17599.full.pdf

D. Bua and O. Binda, The Return of the INGs, Histone Mark Sensors and Phospholipid Signaling Effectors, Current Drug Targets, vol.10, issue.5, pp.418-431, 2009.
DOI : 10.2174/138945009788185112

U. Burska, V. Harle, K. Coffey, S. Darby, H. Ramsey et al., Deubiquitinating Enzyme Usp12 Is a Novel Co-activator of the Androgen Receptor, Journal of Biological Chemistry, vol.288, issue.45, pp.32641-32650, 2013.
DOI : 10.1093/nar/gkq1352

M. Centenera, J. Gillis, A. Hanson, S. Jindal, R. Taylor et al., Evidence for Efficacy of New Hsp90 Inhibitors Revealed by Ex Vivo Culture of Human Prostate Tumors, Clinical Cancer Research, vol.18, issue.13, pp.3562-3570, 2012.
DOI : 10.1158/1078-0432.CCR-12-0782

M. Centenera, G. Raj, K. Knudsen, W. Tilley, and L. Butler, Ex vivo culture of human prostate tissue and drug development, Nature Reviews Urology, vol.9, issue.8, pp.483-487, 2013.
DOI : 10.1186/1471-2407-6-246

E. Cerami, J. Gao, U. Dogrusoz, B. Gross, S. Sumer et al., The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data: Figure 1., Cancer Discovery, vol.2, issue.5, pp.401-404, 2012.
DOI : 10.1158/2159-8290.CD-12-0095

G. Chen, Y. Wang, M. Garate, J. Zhou, and G. Li, The tumor suppressor ING3 is degraded by SCFSkp2-mediated ubiquitin???proteasome system, Oncogene, vol.165, issue.10, pp.1498-1508, 2010.
DOI : 10.2217/14796694.1.5.567

K. Coffey, L. Rogerson, C. Ryan-munden, D. Alkharaif, J. Stockley et al., The lysine demethylase, KDM4B, is a key molecule in androgen receptor signalling and turnover, Nucleic Acids Research, vol.66, issue.8, pp.4433-4446, 2013.
DOI : 10.1158/0008-5472.CAN-05-1341

A. Coles, H. Gannon, A. Cerny, K. , E. Jones et al., Inhibitor of growth-4 promotes I??B promoter activation to suppress NF-??B signaling and innate immunity, Proceedings of the National Academy of Sciences, vol.67, issue.5, pp.11423-11428, 2010.
DOI : 10.1158/0008-5472.CAN-06-3558

A. Coles, H. Liang, Z. Zhu, C. Marfella, J. Kang et al., Deletion of p37Ing1 in Mice Reveals a p53-Independent Role for Ing1 in the Suppression of Cell Proliferation, Apoptosis, and Tumorigenesis, Cancer Research, vol.67, issue.5, pp.2054-2061, 2007.
DOI : 10.1158/0008-5472.CAN-06-3558

Y. Doyon, C. Cayrou, M. Ullah, A. Landry, V. Côté et al., ING Tumor Suppressor Proteins Are Critical Regulators of Chromatin Acetylation Required for Genome Expression and Perpetuation, Molecular Cell, vol.21, issue.1, pp.51-64, 2006.
DOI : 10.1016/j.molcel.2005.12.007

Y. Doyon, W. Selleck, W. Lane, S. Tan, and J. Côté, Structural and Functional Conservation of the NuA4 Histone Acetyltransferase Complex from Yeast to Humans, Molecular and Cellular Biology, vol.24, issue.5, pp.1884-1896, 2004.
DOI : 10.1128/MCB.24.5.1884-1896.2004

J. Ferlay, I. Soerjomataram, R. Dikshit, S. Eser, C. Mathers et al., Cancer incidence and mortality worldwide: sources, methods and major patterns, 2012.

R. Ferraldeschi, J. Welti, J. Luo, G. Attard, and J. De-bono, Targeting the androgen receptor pathway in castration-resistant prostate cancer: progresses and prospects, Oncogene, vol.15, issue.14, pp.1745-1757, 2015.
DOI : 10.1593/neo.121550

J. Gao, B. Aksoy, U. Dogrusoz, G. Dresdner, B. Gross et al., Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal, Science Signaling, vol.26, issue.18, p.1, 2013.
DOI : 10.1093/bioinformatics/btq430

I. Garkavtsev, A. Kazarov, A. Gudkov, and K. Riabowol, Suppression of the novel growth inhibitor p33ING1 promotes neoplastic transformation, Nature Genetics, vol.92, issue.4, pp.415-420, 1996.
DOI : 10.1016/0092-8674(89)90914-8

L. Gaughan, I. Logan, S. Cook, D. Neal, and C. Robson, Tip60 and Histone Deacetylase 1 Regulate Androgen Receptor Activity through Changes to the Acetylation Status of the Receptor, Journal of Biological Chemistry, vol.17, issue.29, pp.25904-25913, 2002.
DOI : 10.1074/jbc.C000909200

T. Hung, O. Binda, K. Champagne, A. Kuo, K. Johnson et al., ING4 Mediates Crosstalk between Histone H3 K4 Trimethylation and H3 Acetylation to Attenuate Cellular Transformation, Molecular Cell, vol.33, issue.2, pp.248-256, 2009.
DOI : 10.1016/j.molcel.2008.12.016

URL : https://doi.org/10.1016/j.molcel.2008.12.016

J. Kamine, B. Elangovan, T. Subramanian, D. Coleman, and G. Chinnadurai, Identification of a Cellular Protein That Specifically Interacts with the Essential Cysteine Region of the HIV-1 Tat Transactivator, Virology, vol.216, issue.2, pp.357-366, 1996.
DOI : 10.1006/viro.1996.0071

L. Kelley and M. Sternberg, Protein structure prediction on the Web: a case study using the Phyre server, Nature Protocols, vol.5, issue.3, pp.363-371, 2009.
DOI : 10.1093/nar/gkm977

J. Kichina, M. Zeremski, L. Aris, K. Gurova, E. Walker et al., Targeted disruption of the mouse ing1 locus results in reduced body size, hypersensitivity to radiation and elevated incidence of lymphomas, Oncogene, vol.25, issue.6, pp.857-866, 2006.
DOI : 10.1038/sj.onc.1209118

S. Kim, S. Natesan, G. Cornilescu, S. Carlson, M. Tonelli et al., Mechanism of Histone H3K4me3 Recognition by the Plant Homeodomain of Inhibitor of Growth 3, Journal of Biological Chemistry, vol.139, issue.35, pp.18326-18341, 2016.
DOI : 10.4161/epi.28864

T. Kirkegaard, J. Edwards, S. Tovey, L. Mcglynn, S. Krishna et al., Observer variation in immunohistochemical analysis of protein expression, time for a change?, Histopathology, vol.7, issue.7, pp.787-794, 2006.
DOI : 10.1023/A:1021399923825

R. Kuner, M. Falth, N. Pressinotti, J. Brase, S. Puig et al., The maternal embryonic leucine zipper kinase (MELK) is upregulated in high-grade prostate cancer, Journal of Molecular Medicine, vol.70, issue.1, pp.237-248, 2013.
DOI : 10.1158/0008-5472.CAN-09-2183

S. Mcnicholas, E. Potterton, K. Wilson, and M. Noble, molecular-graphics software, Acta Crystallographica Section D Biological Crystallography, vol.20, issue.4, pp.386-394, 2011.
DOI : 10.1016/S0968-0004(00)89080-5

A. Nabbi, A. Almami, S. Thakur, K. Suzuki, D. Boland et al., ING3 protein expression profiling in normal human tissues suggest its role in cellular growth and self-renewal, European Journal of Cell Biology, vol.94, issue.5, pp.214-222, 2015.
DOI : 10.1016/j.ejcb.2015.03.002

A. Nabbi, U. Mcclurg, S. Thalappilly, A. Almami, M. Mobahat et al., ING3 promotes prostate cancer growth by activating the androgen receptor, BMC Medicine, vol.17, issue.5, p.103, 2017.
DOI : 10.1016/j.ccr.2010.03.018

URL : https://bmcmedicine.biomedcentral.com/track/pdf/10.1186/s12916-017-0854-0?site=bmcmedicine.biomedcentral.com

M. Nagashima, M. Shiseki, R. Pedeux, S. Okamura, M. Kitahama-shiseki et al., A novel PHD-finger motif protein, p47ING3, modulates p53-mediated transcription, cell cycle control and apoptosis, Oncogene, vol.22, issue.3, pp.343-350, 2003.
DOI : 10.1038/35042675

URL : http://www.nature.com/onc/journal/v22/n3/pdf/1206115a.pdf

O. Neill, D. Williamson, S. Alkharaif, D. Monteiro, I. Goudreault et al., SETD6 controls the expression of estrogen-responsive genes and proliferation of breast carcinoma cells, Epigenetics, vol.36, issue.7, pp.942-950, 2014.
DOI : 10.1038/sj.onc.1211014

A. Obri, K. Ouararhni, C. Papin, M. Diebold, K. Padmanabhan et al., ANP32E is a histone chaperone that removes H2A.Z from chromatin, Nature, vol.9, issue.7485, pp.648-653, 2014.
DOI : 10.1186/gb-2008-9-9-r137

T. Riley, E. Sontag, P. Chen, and A. Levine, Transcriptional control of human p53-regulated genes, Nature Reviews Molecular Cell Biology, vol.18, issue.5, pp.402-412, 2008.
DOI : 10.1128/MCB.15.4.2157

M. Saito, K. Kumamoto, A. Robles, I. Horikawa, B. Furusato et al., Targeted Disruption of Ing2 Results in Defective Spermatogenesis and Development of Soft-Tissue Sarcomas, PLoS ONE, vol.125, issue.11, p.15541, 2010.
DOI : 10.1371/journal.pone.0015541.s013

X. Shi, T. Hong, K. Walter, M. Ewalt, E. Michishita et al., ING2 PHD domain links histone H3 lysine 4 methylation to active gene repression, Nature, vol.124, issue.7098, pp.96-99, 2006.
DOI : 10.1016/j.cell.2005.11.044

URL : http://europepmc.org/articles/pmc3089773?pdf=render

T. Wang, S. Guo, Z. Liu, L. Wu, M. Li et al., CAMK2N1 inhibits prostate cancer progression through androgen receptor-dependent signaling, Oncotarget, vol.5, issue.21, pp.10293-10306, 2014.
DOI : 10.18632/oncotarget.2511

URL : http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article&op=download&path%5B%5D=2511&path%5B%5D=4552

T. Wang, Z. Liu, S. Guo, L. Wu, M. Li et al., The tumor suppressive role of CAMK2N1 in castration-resistant prostate cancer, Oncotarget, vol.5, issue.11, pp.3611-3621, 2014.
DOI : 10.18632/oncotarget.1968

Y. Wong, R. Ferraldeschi, G. Attard, and J. De-bono, Evolution of androgen receptor targeted therapy for advanced prostate cancer, Nature Reviews Clinical Oncology, vol.72, issue.6, pp.365-376, 2014.
DOI : 10.1158/1078-0432.CCR-10-0567

T. Yamamoto and M. Horikoshi, Novel Substrate Specificity of the Histone Acetyltransferase Activity of HIV-1-Tat Interactive Protein Tip60, Journal of Biological Chemistry, vol.15, issue.49, pp.30595-30598, 1997.
DOI : 10.1101/gad.11.13.1640